Human VEGF R3/FLT4 Protein (VGF-HM2R3)
Human VEGF R3/FLT4 Protein (VGF-HM2R3)
Human VEGF R3/FLT4 Protein (VGF-HM2R3)
  • Express System: HEK293
  • Product Tag: C-hFc
  • Purity: > 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC
  • Activity: Immobilized Human VEGF-C, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human VEGF R3, hFc Tag with the EC50 of 11.7ng/ml determined by ELISA (QC Test). See testing image for detail.
  • Amino Acid Range: Tyr25-Ile776
Catalog #VGF-HM2R3
Regular price $346.50
/
Size

Order now, ships by:

Product Description

Recombinant Human VEGF R3/FLT4 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Tyr25-Ile776.

Product Background

Vascular endothelial growth factor (VEGF) and its receptors VEGF-R1, -R2 and -R3 play important roles in tumor angiogenesis and are associated with poor prognosis in several solid tumors.VEGF-R1, -R2 and -R3 were highly expressed in CRC cells and stromal vessels. VEGF-R1 strong positive staining correlated with shorter survival after CRC surgery.

Product Category

Recombinant Protein / Antibody discovery / CAR-T targets

Protein

VEGF R3/FLT4

Synonyms

VEGFR-3; FLT-4; LMPH1A; PCLFLT41; VEGFR3; FLT-41; PCL

Accession

Species

Human

Biotinylated

no

Amino Acid Range

Tyr25-Ile776

Molecular Weight

The protein has a predicted MW of 111.3 kDa. Due to glycosylation, the protein migrates to 135-155 kDa based on Bis-Tris PAGE result.

Activity

Immobilized Human VEGF-C, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human VEGF R3, hFc Tag with the EC50 of 11.7ng/ml determined by ELISA (QC Test). See testing image for detail.

Product Tag

C-hFc

Expression System

HEK293

Purity

> 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC

Endotoxin

Less than 1 EU per ug by the LAL method.
Form
Lyophilized
Shipping
Shipped at ambient temperature.
Formulation
Lyophilized from 0.22um filtered solution in 50mM Tris, 150mM NaCl, 100mM Glycine (pH 7.5). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution
Dissolve the lyophilized protein in distilled water. It is recommended to resuspend at 0.5 mg/mL if the lyophilized powder is 100 ug or less, at 1mg/ml for 500ug or 1mg lyophilized powder. Do not mix by vortex or vigorous shaking.
Stability And Storage
-20 to -80°C for 12 months as supplied from date of receipt.;-80°C for 3 months after reconstitution.;Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Immobilized Human VEGF-C, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human VEGF R3, hFc Tag with the EC50 of 11.7ng/ml determined by ELISA (QC Test). Immobilized Human VEGF-C, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human VEGF R3, hFc Tag with the EC50 of 11.7ng/ml determined by ELISA (QC Test).
Immobilized Human VEGF R3, hFc Tag at 2ug/ml (100ul/well) on the plate. Dose response curve for Human VEGF-D, His Tag with the EC50 of 0.44ug/ml determined by ELISA. Immobilized Human VEGF R3, hFc Tag at 2ug/ml (100ul/well) on the plate. Dose response curve for Human VEGF-D, His Tag with the EC50 of 0.44ug/ml determined by ELISA.
Human VEGF R3 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. Human VEGF R3 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Human VEGF R3 is greater than 95% as determined by SEC-HPLC. The purity of Human VEGF R3 is greater than 95% as determined by SEC-HPLC.

Have more questions?

Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.

Contact Us

support@kactusbio.us

Recently viewed